Atlas Trials

Yang Donglin

1 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Yang Donglin

RecordFirmDate
A Randomized Controlled Trial of Prophylactic Rituximab to Reduce Clinically Significant EBV DNAemia After Allogeneic Hematopoietic Stem Cell Transplantation (NCT07703657)Yang Donglin2026-07-09

Track Yang Donglin automatically

Every clearance here is in the API, with alerts when new ones post.